Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis.

RATIONALE Studies of pregnancy in cystic fibrosis (CF) have shown no short-term harmful effects, but there are no long-term studies on the impact of motherhood. OBJECTIVES This study sought to evaluate longer-term physiologic and functional outcomes in women with CF reporting a pregnancy, with the intent of assessing how the demands of parenting impacted on disease course. METHODS Using 1994 to 2005 Epidemiologic Study of Cystic Fibrosis data, we developed a propensity score to match women reporting a pregnancy at a 1:10 ratio with never-pregnant control subjects and compared clinical outcomes, health-related quality of life, and health care use. MEASUREMENTS AND MAIN RESULTS One hundred nineteen pregnant women presumed to have become mothers were matched with 1,190 control subjects, a median of 6.0 years (range 1.8-11.1 yr) from the pregnancy. No differences were found in annualized change from baseline FEV1 and body mass index, in respiratory signs and symptoms, or in prescribed chronic therapies. Women who had been pregnant were treated for more pulmonary exacerbations and had more illness-related clinic visits but showed no increase in prescribed chronic therapies. They also reported lower health-related quality-of-life scores for Respiratory Symptoms, Physical Functioning, Vitality, and Health Perceptions. CONCLUSIONS Pregnancy and motherhood do not appear to accelerate disease progression but lead to more illness-related visits, pulmonary exacerbations, and a decrease in some domains of quality of life. These differences presumably reflect the impact of the physical and emotional challenges of early motherhood on disease self-management.

[1]  G. Sawicki,et al.  Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample , 2012, Quality of Life Research.

[2]  G. Sawicki,et al.  Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample , 2012, Quality of Life Research.

[3]  J. Avorn,et al.  Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. , 2010, American journal of epidemiology.

[4]  A. Quittner,et al.  Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. , 2010, Chest.

[5]  S. McColley,et al.  Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. , 2009, The Journal of pediatrics.

[6]  Susan B. Coyle Health-Related Quality of Life of Mothers: A Review of the Research , 2009, Health care for women international.

[7]  J. Haro,et al.  Methodological aspects in the assessment of treatment effects in observational health outcomes studies , 2006, Applied health economics and health policy.

[8]  Til Stürmer,et al.  Indications for propensity scores and review of their use in pharmacoepidemiology. , 2006, Basic & clinical pharmacology & toxicology.

[9]  W. Morgan,et al.  Impact of pregnancy on women with cystic fibrosis. , 2006, Chest.

[10]  A. Quittner,et al.  Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. , 2005, Chest.

[11]  J. Nick,et al.  The Metabolic Effects of Pregnancy in Cystic Fibrosis , 2005, Obstetrics and gynecology.

[12]  C. Goss,et al.  The effect of pregnancy on survival in women with cystic fibrosis. , 2003, Chest.

[13]  K. Rothman,et al.  Mortality of Cystic Fibrosis Patients Treated with Tobramycin Solution for Inhalation , 2003, Epidemiology.

[14]  M. Corey,et al.  Pregnancy in cystic fibrosis. Fetal and maternal outcome. , 2000, Chest.

[15]  Charles A. Johnson,et al.  Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada , 1999, Pediatric pulmonology.

[16]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[17]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[18]  David Wypij,et al.  Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.